Early Feasibility Study of Cartilage Defect Repair

Part of paid clinical trials in St Louis, Missouri.

Sponsor
Cytex Therapeutics, Inc.
Study ID
NCT06823089
Status
Recruiting
Apply to this trial

Conditions

  • Femoroacetabular Impingement
  • Hip Dysplasia
  • Legg-Calvé-Perthes Disease
  • Osteoarthritis, Hip
  • Osteochondral Lesion
  • Osteonecrosis

Eligibility Criteria

Sex
ALL
Age
14 Years - 64 Years
Healthy Volunteers
Not accepted

Interventions

  • ReNew Hip Implant — DEVICE
    Surgical Intervention

Study Details

Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.

Key Dates

Start date
Nov 6, 2025
Status verified
Feb 2026
Primary completion
Oct 31, 2031
Completion
Oct 31, 2031

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Investigational Arm
    The investigation device for this study will be the ReNew Hip Implant.

Primary Outcome Measure

To establish initial safety (adverse events and device related serious adverse events) and effectiveness (pain and function) of the ReNew Hip Implant [ Time Frame: 6, 12, and 60 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Washington University School of MedicineSt LouisMissouri63110
Zak Robben
[email protected]
314-873-0738
Caroline Drain
[email protected]
Jeffrey Nepple, MD (PRINCIPAL_INVESTIGATOR)
John Clohisy, MD (SUB_INVESTIGATOR)

Find similar trials in St Louis, MO

By research site
Washington University School of Medicine· St Louis, MO

Related Studies